2021 Coronary Revascularization Guidelines—Lessons in the Importance of Data Scrutiny and Reappraisal of Evidence-Reference-Cited by-同舟云学术

2021 Coronary Revascularization Guidelines—Lessons in the Importance of Data Scrutiny and Reappraisal of Evidence

Published:2023-03-01 Issue:3 Volume:158 Page:233
ISSN:2168-6254
Container-title:JAMA Surgery
language:en
Short-container-title:JAMA Surg

Author:

Bakaeen Faisal G.¹,Chu Danny²,Dayan Victor³

Affiliation:

1. Coronary Center, Department of Thoracic and Cardiovascular Surgery, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio

2. Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center Heart & Vascular Surgery, Pittsburgh, Pennsylvania

3. Centro Cardiovascular Universitario, Montevideo, Uruguay

Abstract

This Viewpoint discusses whether or not the evidence cited in the 2021 American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography &amp; Interventions guidelines for coronary artery revascularization support downgrading coronary artery bypass grafting relative to medical therapy.

Publisher

American Medical Association (AMA)

Subject

Surgery

Link

https://jamanetwork.com/journals/jamasurgery/articlepdf/2798992/jamasurgery_bakaeen_2022_vp_220027_1678202755.57036.pdf

Reference7 articles.

1. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines.;Lawton;J Am Coll Cardiol,2022

2. The American Association for Thoracic Surgery and the Society of Thoracic Surgeons reasoning for not endorsing the 2021 ACC/AHA/SCAI Coronary Revascularization Guidelines.;Sabik;J Thorac Cardiovasc Surg,2022

3. Initial invasive or conservative strategy for stable coronary disease.;Maron;N Engl J Med,2020

4. Routine revascularization vs initial medical therapy for stable ischemic heart disease: a systematic review and meta-analysis of randomized trials.;Bangalore;Circulation,2020

5. Outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity.;Reynolds;Circulation,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary Artery Surgery: Past, Present, and Future;Rambam Maimonides Medical Journal;2024-01-19

2. STS/AATS-endorsed rebuttal to 2023 ACC/AHA Chronic Coronary Disease Guideline: A missed opportunity to present accurate and comprehensive revascularization recommendations;The Journal of Thoracic and Cardiovascular Surgery;2023-10

3. STS/AATS-Endorsed Rebuttal to 2023 ACC/AHA Chronic Coronary Disease Guideline: A Missed Opportunity to Present Accurate and Comprehensive Revascularization Recommendations;The Annals of Thoracic Surgery;2023-10